期刊文献+

他汀类药物成功治愈左侧颈动脉狭窄1例分析 被引量:1

A Successfully Cured Case with Left Carotid Artery Stenosis Treated by Statins
下载PDF
导出
摘要 他汀类药物为临床常用调脂药物,能较好地改善动脉粥样硬化。本例左侧颈动脉狭窄患者经过5个月的他汀类药物治疗后成功治愈,现报道如下。 Statins are commonly used cholesterol-lowering drugs,have good effect in improving symptoms of atherosclerosis. This paper reported one case with left carotid stenosis that successfully cured by five-month statins therapy.
作者 占日新
出处 《临床合理用药杂志》 2015年第3期131-132,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 颈动脉狭窄 他汀类药物 病例报告 Carotid Stenosis Statins Case report
  • 相关文献

参考文献8

二级参考文献41

  • 1Kner N, Marah J D. Pathobiology of atheroaclerosis: a brief review[J]. Semin Thromb Hernast, 2004,30 (6) : 665-672.
  • 2Reiner Zeachi-reiner E. New information on the pathophysiology of atherosclerosis of atherosclerosis[J]. Lijec Vjesn,2001,123(1- 2) :26-31.
  • 3Bolli R, Shinmura K, Tang X L, et al. Discovery of a new function of cyclooxygenasc ( COX )-2: COX 2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning [J]. Cardiovasc Res,2002,55(3) :506- 519.
  • 4Loll P J, Picot D, Garavito R M, et al. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase[J]. Nat Struct Biol,1995,2(8):637- 643.
  • 5Ross R. Atherosclerosis: an inflammatory disease[J]. N Eng J Med,1999,340(2) :115-126.
  • 6Yin M J, Yamamoto Y, Gaynor R B. The anti-inflammatory agents aspirin and salieylate inhibit the activity of 1 (kappa) B kinase beta[J].Nature,1998,396(6706):77-80.
  • 7Shi X, Ding M, Dong Z, et ah Antioxidant properties of aspirin: characterization of the ability to inhibit silica induced lipid peroxidation, DNA damage, NF KB activation, and TNF alpha production[J].Mol Cell Biochem,1999,199(1- 2): 93-102.
  • 8Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: Isls 2. Isis-2 (Second International Study of Infarct Survival) Collaborative Group[J].Lancet, 1988, 2 (8607) :349-360.
  • 9Grosscr T, Fries S, FitzGerald G A. Biological basis forthecardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities[J]. J Clin Invest, 2006,116 (1) : 4- 15.
  • 10Antithrombotic Trialists' CollaBoration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high riskpatients[J].BMJ,2002,324(7329):71-86.

共引文献60

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部